In typical CLL cases, the tumor B cell clone exhibits an abnormal expression of markers like CD5, CXCR4, and ZAP-70, that are used to stratify the disease in conjunction with the mutational status of the BCR reflecting different cell of origin (25, 26). This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.